Barry Guld

Mr. Guld is an entrepreneur, advisor, founder and investor in healthcare and technology companies. He started his career at IBM, moving on as founder of Zadall Systems (now part of McKesson) and as a co-founder or investor in several HealthIT companies including pc/1, PDX, eRx. He is the founder and CEO of Methylation Sciences Inc., a clinical-stage pharmaceutical company. Mr. Guld manages investments for his investment company, Ladaz Technologies, Inc. and he is currently a director of the Mark Anthony Group, owner of wineries and brands such as White Claw and Mike’s Hard Lemonade and a director of Prescryptive, a HealthIT SaaS platform designed to massively disrupt drug delivery and improve wellness.